Home The Word Brain My Amedeo FAQ Privacy About


Amedeo Chinese

For Medical Students & Physicians

A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever.

Download the free PDF: Amedeo Chinese PDF

  Autoimmune Disorders

  Free Subscription


Articles published in PLoS One

Retrieve available abstracts of 304 articles:
HTML format



Single Articles


    January 2026
  1. PRUST ML, Lalama CM, Kehlenbrink S, Akinola OA, et al
    Economic evaluation of insulin glargine compared with human insulin for youth with type 1 diabetes in Tanzania and Bangladesh.
    PLoS One. 2026;21:e0333652.
    PubMed     Abstract available


  2. CARDINI R, Gervasoni E, Germanotta M, Aprile IG, et al
    Consensus on recommended evaluation tools in multiple sclerosis (CORE-MS): A Delphi study protocol on balance and gait assessment.
    PLoS One. 2026;21:e0337440.
    PubMed     Abstract available


  3. YANG D, Zhang Y, Ji L, Wu J, et al
    The shared biomarkers and molecular mechanisms of systemic lupus erythematosus and type 2 diabetes.
    PLoS One. 2026;21:e0340312.
    PubMed     Abstract available


  4. HOWREN A, Tran QL, Sediqi S, Hawa S, et al
    Effect of race and sex on lupus diagnosis in primary care: A randomized factorial survey study.
    PLoS One. 2026;21:e0342328.
    PubMed     Abstract available


  5. SIKET M, Kovacs L, Eigner G
    Stochastic virtual population in type 1 diabetes.
    PLoS One. 2026;21:e0341034.
    PubMed     Abstract available


  6. AHABWENKI R, Piloya T, Namiiro F, Muzeyi W, et al
    Impact of COVID-19 on New - onset Type 1 diabetes mellitus: A six-year retrospective review from two Paediatric clinics, Kampala, Uganda.
    PLoS One. 2026;21:e0341145.
    PubMed     Abstract available


  7. XUE H, Li B, Wang X, Zhao J, et al
    Performance evaluation and reference interval establishment of Abbott Alinity thyroid-stimulating hormone receptor antibody (TRAb) assay for diagnosing Graves' disease.
    PLoS One. 2026;21:e0339494.
    PubMed     Abstract available


  8. BIAN L, Yang C, Jin Y, Wang H, et al
    Association between carbohydrate quality and glycemic control in individuals with type 1 diabetes: A cross-sectional and meal-based analysis.
    PLoS One. 2026;21:e0341915.
    PubMed     Abstract available


  9. YANG B, Molton I, Humbert A, Baylor C, et al
    Environmental influences on community participation among people with multiple sclerosis: A mixed methods study.
    PLoS One. 2026;21:e0342678.
    PubMed     Abstract available


  10. MUSTERER S, Vogel M, Kiess W, Richter S, et al
    Cardiac markers in children and adolescents at the onset of type 1 diabetes mellitus.
    PLoS One. 2026;21:e0342397.
    PubMed     Abstract available


  11. DENG Q, Bai Q, Yang Y, Tang W, et al
    A new mechanism regulating microglial NLRP3 inflammasome: FMR1 mediates NLRP3 mRNA stability.
    PLoS One. 2026;21:e0341867.
    PubMed     Abstract available


  12. AKBARI H, Ragerdi-Kashani I, Rezaei-Yazdi F, Pasbakhsh P, et al
    Effect of transplanted oligodendrocyte precursor cells derived from inflammatory and non-inflammatory microenvironment on remyelination in a chronic cuprizone model.
    PLoS One. 2026;21:e0343039.
    PubMed     Abstract available


  13. SWOLIN-EIDE D, Pundziute Lycka A, Forsander G, Novak D, et al
    Independent validation of circulating microRNAs as biomarkers in a case-control study of adolescents with type 1 diabetes for more than 8 years.
    PLoS One. 2026;21:e0343117.
    PubMed     Abstract available


  14. TAUFIQQURRACHMAN I, Witarto AP, Syam AF, Abdullah M, et al
    Diagnostic potential of total serum ghrelin in autoimmune gastritis: A systematic review and meta-analysis.
    PLoS One. 2026;21:e0344129.
    PubMed     Abstract available


  15. GIORDANO A, De Panfilis L, Zagarella RM, Di Domenico G, et al
    Communication competences of multiple sclerosis neurologists during advance care planning conversations: A multi-observer study.
    PLoS One. 2026;21:e0336183.
    PubMed     Abstract available


  16. LIANG C, Zhuo P, Zhang Y
    Leukotriene receptor antagonists and eosinophilic granulomatosis with polyangiitis: a disproportionality analysis from FAERS, JADER, CVAR databases integrated with network pharmacology.
    PLoS One. 2026;21:e0343084.
    PubMed     Abstract available


  17. MIRMOSAYYEB O, Mohammadi I, Rajai Firouzabadi S, Vaheb S, et al
    Cognitive function is associated with risk of conversion to secondary progressive multiple sclerosis: A cross-sectional study.
    PLoS One. 2026;21:e0344558.
    PubMed     Abstract available


  18. SUN Y, Wei J, Zhao Y, Jiang X, et al
    GBP2 promotes podocyte pyroptosis and contributes to the pathogenesis of pediatric lupus nephritis.
    PLoS One. 2026;21:e0344601.
    PubMed     Abstract available


  19. LIU L, Jacobson B, Stefanovic D
    PID-controller enhanced artificial beta-cells.
    PLoS One. 2026;21:e0342799.
    PubMed     Abstract available


  20. NESBITT C, Rayner G, Timmens K, Kazzi C, et al
    Study protocol for a mixed methods convergent investigation of family domestic and sexual violence in multiple sclerosis and broader neurology in Australia.
    PLoS One. 2026;21:e0344667.
    PubMed     Abstract available


  21. DELLBRUGGE F, Loges S, Henjes N, Wedemeyer H, et al
    Comparative evaluation of immunoserological detection of F-actin antibodies.
    PLoS One. 2026;21:e0345250.
    PubMed     Abstract available


  22. TAJALI S, Scandiffio J, Ali-Hassan Y, Lim D, et al
    A pilot randomized controlled trial of neuromodulation-augmented balance training in people with multiple sclerosis: STIM-Balance Protocol.
    PLoS One. 2026;21:e0346491.
    PubMed     Abstract available


  23. ZANOTTO T, Tabatabaei A, Lynch SG, He J, et al
    Reducing frailty in frail people with multiple sclerosis: Feasibility of a 6-week multimodal exercise training program.
    PLoS One. 2026;21:e0347063.
    PubMed     Abstract available


  24. YTTERDAL M, Sandvik CE, Holmoy T, Bo L, et al
    The neural transdifferentiation potential of bone marrow mesenchymal stem cells.
    PLoS One. 2026;21:e0347119.
    PubMed     Abstract available


  25. VILAR-LLUCH S, Knight D
    Type 1 and Type 2 diabetes in the UK press: A diachronic corpus-based analysis.
    PLoS One. 2026;21:e0348079.
    PubMed     Abstract available


  26. FU Q, Li J, Gu X, Zhang Y, et al
    Artemether ameliorates type 1 diabetic liver injury alongside the associated defects in mitochondrial ultrastructure and central carbon metabolism.
    PLoS One. 2026;21:e0348214.
    PubMed     Abstract available


  27. KWON C, Oh J, Shin HJ
    Comparative study of ocular and generalized myasthenia gravis in a South Korean cohort.
    PLoS One. 2026;21:e0346981.
    PubMed     Abstract available


  28. WIDYASTUTI ESA, Lavina J, Darmajaya GJ, Sumantri S, et al
    Associated factors of health-related quality of life in Indonesian Women with Systemic Lupus Erythematosus: A cross-sectional within-cohort analysis.
    PLoS One. 2026;21:e0341989.
    PubMed     Abstract available


  29. PARK JH, Lee MT, Jung SY, Choi ST, et al
    Association between coronavirus disease 2019 and new-onset autoimmune diseases during the early phase of the pandemic.
    PLoS One. 2026;21:e0347872.
    PubMed     Abstract available


  30. VERSTER F, Bowden N, Schluter PJ, Chepulis L, et al
    Life expectancy and mortality of people with and without diabetes in Aotearoa | New Zealand: A national cohort study.
    PLoS One. 2026;21:e0345892.
    PubMed     Abstract available


  31. SINAN NA, Almujaydil MS
    Cafestol ameliorates diabetic nephropathy via Keap1-Nrf2 axis activation: A novel renoprotective mechanism independent of glycemic control.
    PLoS One. 2026;21:e0349192.
    PubMed     Abstract available


  32. SU S, Lin Y
    Identification of a diagnostic metabolomic fingerprint in plasma for eosinophilic granulomatosis with polyangiitis.
    PLoS One. 2026;21:e0343182.
    PubMed     Abstract available


  33. DASTANI M, Sajjadi MS, Yamout B, Arab Bafrani M, et al
    Evaluation of the performance of large language models in responding to medical questions related to multiple sclerosis: A case study of large language models including ChatGPT, Gemini, Grok and Copilot.
    PLoS One. 2026;21:e0346445.
    PubMed     Abstract available


  34. SINGHAL P, Srivastava P, Rajasekhar L
    Psychological well-being of SLE patients: A comprehensive examination of stress, depression, anxiety and quality of life.
    PLoS One. 2026;21:e0344330.
    PubMed     Abstract available


  35. LUO Y, Gao H, Wang M, Wang Z, et al
    The ketogenic diet alleviates autoimmune thyroiditis caused by Th17/Treg imbalance by inhibiting the HMGB1/NLRP3 signaling pathway.
    PLoS One. 2026;21:e0341564.
    PubMed     Abstract available


  36. NAKAJIMA T, Kitagori K, Funakoshi S, Shirakashi M, et al
    Significance of RGS13 expression in lupus B cells.
    PLoS One. 2026;21:e0348945.
    PubMed     Abstract available


  37. ALWABRAN AI, Aldoseri GM, Aldoseri GM, Mohager SO, et al
    Decoding the genetic basis of demyelination: Prediction of potential pathogenic coding and regulatory noncoding MBP SNPs in multiple sclerosis.
    PLoS One. 2026;21:e0347598.
    PubMed     Abstract available


  38. DENG Y, Tang Z, Chen Q, Hu X, et al
    Computational biology exposed a common pathogenic mechanism in influenza A and Guillain-Barre syndrome.
    PLoS One. 2026;21:e0349687.
    PubMed     Abstract available


  39. LAI KKH, Aljufairi FMAA, Sebastian JU, Liao X, et al
    Cornea biomechanics and biometric evaluations in immunoglobulin G4-related ophthalmic disease.
    PLoS One. 2026;21:e0347998.
    PubMed     Abstract available


  40. XU M, Cheng Q, Xie Y, Chen X, et al
    Multi-omics profiling reveals epidermal growth factor as a potential biomarker and therapeutic target in lupus nephritis and ANCA-associated vasculitis with rapidly progressive glomerulonephritis.
    PLoS One. 2026;21:e0349307.
    PubMed     Abstract available


  41. SRIMANAN W, Keokajee P, Sawangsribanterng S
    A preliminary cost-utility analysis of routine myasthenia gravis and thyroid dysfunction screening in acquired comitant Esotropia.
    PLoS One. 2026;21:e0350280.
    PubMed     Abstract available


  42. GUALCO C, Grange E, Rotondi F, Salivetto M, et al
    Vocational rehabilitation for people with multiple sclerosis: A systematic scoping review of international evidence.
    PLoS One. 2026;21:e0350122.
    PubMed     Abstract available


  43. HARUNA Y, Tagami M, Kurosaki R, Nishio M, et al
    Development and evaluation of AI model with deep learning for segmentation of extraocular muscles in thyroid eye disease.
    PLoS One. 2026;21:e0349074.
    PubMed     Abstract available


  44. PICHI F, Jimenez YP, Belletti M, Alsuwaidi A, et al
    Retinal macrophage-like cell activation and ganglion cell layer thinning are associated with disability and MRI lesion burden in multiple sclerosis.
    PLoS One. 2026;21:e0349679.
    PubMed     Abstract available


  45. DENG Y, Shang Y, Zhang Y, Li D, et al
    Inhibition of neutrophil infiltration and NETs formation ameliorates neuropsychiatric and renal dysfunction in MRL/lpr mice with lupus.
    PLoS One. 2026;21:e0348011.
    PubMed     Abstract available


  46. MARIKI A, Kohlmeier KA, Mousavi SM, Keyhani A, et al
    Fasciola hepatica excretory-secretory products attenuate demyelination and reduce neuroinflammation in the Cuprizone -induced multiple sclerosis model.
    PLoS One. 2026;21:e0349675.
    PubMed     Abstract available


  47. MARTIN-BAEZ MY, Diaz-Gonzalez CM
    Preschool and primary school teachers' attitudes toward students with type 1 diabetes: A cross-sectional study.
    PLoS One. 2026;21:e0350813.
    PubMed     Abstract available


  48. STAHL LS, Hickstein J, Kopke S, Hellwig K, et al
    Motherhood choice in multiple sclerosis (MoMS) - Pilot trial of web-based decision support.
    PLoS One. 2026;21:e0351108.
    PubMed     Abstract available


  49. GIOVANNETTI AM, Giordano A, Donarelli E, Di Domenico G, et al
    Quality of life domains revised by people with multiple sclerosis and healthcare professionals for adaptive measure development.
    PLoS One. 2026;21:e0349034.
    PubMed     Abstract available


  50. JAKOB ER, Amireault S, Reed JB, Kao SC, et al
    Potential intervention targets to promote physical activity among people with multiple sclerosis: A scoping review protocol for evidence of moderation.
    PLoS One. 2026;21:e0351882.
    PubMed     Abstract available


  51. GROSMANE-BATARAGA A, Saluvera E, Roddate M, Krutovs V, et al
    Evaluation of plasma neurofilament light chain and glial fibrillary acidic protein in myasthenia gravis: A controlled cohort study.
    PLoS One. 2026;21:e0352017.
    PubMed     Abstract available


  52. MUHWAVA L, Marban-Castro E, Silima M, Karsas M, et al
    Exploring the feasibility and acceptability of Continuous Glucose Monitoring among people with type 1 diabetes and healthcare providers in South Africa's public sector: A qualitative study.
    PLoS One. 2026;21:e0352590.
    PubMed     Abstract available


  53. VAUTHIER JC, Kabuth B
    Glycemic meritocracy, sport and care: Between lay expertise and medical recognition.
    PLoS One. 2026;21:e0353885.
    PubMed     Abstract available


  54. HADJ-ABO A, Gusy B, Fleischhauer M
    Comparison of AID users and non-users regarding glycemic control and diabetes distress: A mixed-methods study.
    PLoS One. 2026;21:e0353125.
    PubMed     Abstract available


  55. OHRSTROM MT, Schultz MD, Bistrup C, Birn H, et al
    Incidence and risk factors for recurrent IgA nephropathy after kidney transplantation: A multicenter cohort study from Denmark.
    PLoS One. 2026;21:e0353887.
    PubMed     Abstract available


  56. KAIDAROVA S, Mussazhanova Z, Kozykenova Z, Kurohama H, et al
    Association between autoimmune thyroiditis and BRAFV600E/TERT promoter mutations in patients with papillary thyroid carcinoma from Central Asia, Kazakhstan.
    PLoS One. 2026;21:e0351960.
    PubMed     Abstract available


  57. ZHU K, Barberio J, Tsao N, Mor A, et al
    Trends in the incidence of asthma, atopic dermatitis, and multiple sclerosis before, during, and after the COVID-19 pandemic in a US claims database.
    PLoS One. 2026;21:e0355103.
    PubMed     Abstract available


  58. WU S, Wu Y, Zhang L, Zhu J, et al
    Bisphenol A exposure in myasthenia gravis: Potential targets and mechanisms revealed by network toxicology and molecular dynamics.
    PLoS One. 2026;21:e0354138.
    PubMed     Abstract available


  59. FIGUEIREDO DS, Martinez ARM, Nucci A, Franca Junior MC, et al
    Myasthenia gravis: Diagnostic journey and therapeutic outcomes in patients followed at a Brazilian public tertiary center - A retrospective cohort study.
    PLoS One. 2026;21:e0353883.
    PubMed     Abstract available


  60. DE HERDT D, Lefevere E, Brouwers V, Hartvig L, et al
    Selective GPR17 antagonism enhances structural and functional recovery in animal models of demyelination.
    PLoS One. 2026;21:e0354525.
    PubMed     Abstract available


  61. HAN BS, Seo MS, Kim ES, Song YS, et al
    Orbital computed tomography biomarkers for the assessment of activity of Thyroid Eye Disease.
    PLoS One. 2026;21:e0349838.
    PubMed     Abstract available


  62. TAUL-MADSEN L, Hvid LG, Casu G, Pau M, et al
    Protocol for a pilot effectiveness and feasibility randomized controlled trial of an advanced telerehabilitation system for people with multiple sclerosis (PLATINUMS project).
    PLoS One. 2026;21:e0355376.
    PubMed     Abstract available


  63. VAN WILDER L, Janssens N, Van Hoorenbeeck K, Vanden Wyngaert K, et al
    The COCCOS study: A protocol for a multicentric quasi-experimental study of a healthcare transition program for young people with chronic conditions.
    PLoS One. 2026;21:e0353932.
    PubMed     Abstract available


  64. FREUDENSTEIN D, Schneeweiss A, Krenz A, Gold R, et al
    Diroximel fumarate confers neuroprotection via reduced Th1 responses and induction of the anti-oxidative Nrf2 pathway in experimental neuroinflammation.
    PLoS One. 2026;21:e0355936.
    PubMed     Abstract available


  65. CHAIPRASERT A, Han P, Laomettachit T, Ruengjitchatchawalya M, et al
    Phycocyanobilin: A potential bioactive compound from Arthrospira platensis targeting LYN protein associated with systemic lupus erythematosus.
    PLoS One. 2026;21:e0357093.
    PubMed     Abstract available


  66. SUN B, Lu Y, Liu W, Wang C, et al
    Systems pharmacology reveals type I interferon and myeloid-like B cell reprogramming as candidate druggable axes in antiphospholipid syndrome.
    PLoS One. 2026;21:e0349155.
    PubMed     Abstract available


  67. WESTER TREJO MAC, Kuijper TM, Waverijn GJ, Bajema IM, et al
    ANCA testing strategies: A single centre experience over the past decade in a large teaching hospital in the Netherlands.
    PLoS One. 2026;21:e0357495.
    PubMed     Abstract available


  68. BERRY SA, Iqbal A, Elliott J, Gandhi R, et al
    Pain alleviation in diabetic neuropathy using hybrid closed loop insulin pumps (PAINLESS) - A randomised crossover trial protocol.
    PLoS One. 2026;21:e0357573.
    PubMed     Abstract available


  69. YOO J
    Type I interferon signature strength correlates with alloimmunization-associated transcriptomic programs in systemic lupus erythematosus: A multi-cohort analysis.
    PLoS One. 2026;21:e0347443.
    PubMed     Abstract available


  70. YAMAGUCHI M, Sugiyama H, Kinashi H, Kamiya K, et al
    Clinical outcomes after relapse during rituximab-based maintenance in ANCA-associated vasculitis: A single-center retrospective cohort study.
    PLoS One. 2026;21:e0357836.
    PubMed     Abstract available


  71. LI X, Qiao Y
    Transcriptomic associations and biomarkers in ANCA?associated Glomerulonephritis and IgG4?related Disease: A bioinformatics and machine learning study.
    PLoS One. 2026;21:e0358953.
    PubMed     Abstract available


  72. CHEN Z, Guo Q, Tian L, Jin J, et al
    Identification of rs28362336 as a risk SNP for generalized myasthenia gravis and its impact on HCG27 regulation.
    PLoS One. 2026;21:e0359069.
    PubMed     Abstract available


  73. YANG MK, Ha SJ, Sa HS
    Isolated superior rectus-levator complex enlargement: Inflammatory etiology, clinicoradiological features, and treatment outcomes.
    PLoS One. 2026;21:e0338854.
    PubMed     Abstract available


  74. CHEN X, Lei M, Tang J, Wang H, et al
    Efficacy, safety, and feasibility of youth-derived fecal microbiota transplantation among adults with type 1 diabetes mellitus: A protocol of Pilot Randomized Controlled Trial.
    PLoS One. 2026;21:e0343078.
    PubMed     Abstract available


  75. HE K, Pan B, Tian P, Yang S, et al
    Bioinformatics analysis of genes related to uveitis and differential gene expression in a model of experimental autoimmune uveitis.
    PLoS One. 2026;21:e0358218.
    PubMed     Abstract available


  76. WANG J, Yin Y, Qu J, Tao Z, et al
    Systematic review and network meta-analysis of performance of the Sapporo criteria, the Revised Sapporo criteria, and the 2023 ACR/EULAR APS classification criteria for patients with antiphospholipid syndrome: A protocol.
    PLoS One. 2026;21:e0359310.
    PubMed     Abstract available


  77. YU Y, Banker M, Sherr J, Scholtens DM, et al
    Empirical transition probability modeling of continuous glucose monitoring data.
    PLoS One. 2026;21:e0358361.
    PubMed     Abstract available


    January 2025
  78. CARRASCO S, Liphaus BL, Peixoto TV, Lima TM, et al
    Early neutrophil activation and NETs release in the pristane-induced lupus mice model.
    PLoS One. 2025;20:e0306943.
    PubMed     Abstract available


  79. SIEBALD F, Grittner U, Otto C, Bereuter C, et al
    Ultrasound pupillometry for the detection of a relative afferent pupillary defect (RAPD): Systematic evaluation in patients with optic neuritis and comparison with infrared video pupillometry.
    PLoS One. 2025;20:e0315712.
    PubMed     Abstract available


  80. XU Y, Wang Z, Jia T, Liang S, et al
    Exploring potential drug targets for SLE through Mendelian randomization and network pharmacology.
    PLoS One. 2025;20:e0316481.
    PubMed     Abstract available


  81. KATZ A, Shulkin A, Fortier MA, Yardley JE, et al
    Strategies to reduce hyperglycemia-related anxiety in elite athletes with type 1 diabetes: A qualitative analysis.
    PLoS One. 2025;20:e0313051.
    PubMed     Abstract available


  82. RAO GA, Shoaibi A, Makadia R, Hardin J, et al
    CohortDiagnostics: Phenotype evaluation across a network of observational data sources using population-level characterization.
    PLoS One. 2025;20:e0310634.
    PubMed     Abstract available


  83. TRAN HT, Rodprasert W, Padeta I, Oontawee S, et al
    Establishment of subcutaneous transplantation platform for delivering induced pluripotent stem cell-derived insulin-producing cells.
    PLoS One. 2025;20:e0318204.
    PubMed     Abstract available


  84. OROMO DO
    Pediatric Diabetic Ketoacidosis (PDKA) among newly diagnosed diabetic patients at Dilla University Hospital, Dilla, Ethiopia: Prevalence and predictors.
    PLoS One. 2025;20:e0314433.
    PubMed     Abstract available


  85. VAN REENEN EC, van Nistelrooij IAM, Visser LH, de Beukelaar JWK, et al
    The liminal space between hope and grief: The phenomenon of uncertainty as experienced by people living with relapsing-remitting multiple sclerosis.
    PLoS One. 2025;20:e0315501.
    PubMed     Abstract available


  86. ZHANG S, Hu W, Tang Y, Chen X, et al
    Identification and validation of key autophagy-related genes in lupus nephritis by bioinformatics and machine learning.
    PLoS One. 2025;20:e0318280.
    PubMed     Abstract available


  87. ZHAO YF, Chaw JK, Ang MC, Tew Y, et al
    A safe-enhanced fully closed-loop artificial pancreas controller based on deep reinforcement learning.
    PLoS One. 2025;20:e0317662.
    PubMed     Abstract available


  88. IMAN K, Akter L, Rahman MM, Laila K, et al
    Treatment of refractory poly articular course juvenile idiopathic arthritis with tofacitinib: Extended experience from Bangladesh.
    PLoS One. 2025;20:e0312174.
    PubMed     Abstract available


  89. JAALKHOROL M, Dashtseren A, Magnaibayar G, Bat-Orgil B, et al
    Factors associated with vitamin D levels in Mongolian patients with multiple sclerosis.
    PLoS One. 2025;20:e0317279.
    PubMed     Abstract available


  90. YE W, Ding Y, Li M, Tian Z, et al
    Drug-induced autoimmune-like hepatitis: A disproportionality analysis based on the FAERS database.
    PLoS One. 2025;20:e0317680.
    PubMed     Abstract available


  91. JOERNS EK, Ghebranious MA, Adams TN, Makris UE, et al
    Evaluation of comorbidity burden on disease progression and mortality in patients with interstitial pneumonia with autoimmune features: A retrospective cohort study.
    PLoS One. 2025;20:e0316762.
    PubMed     Abstract available


  92. DAVE S, Rahi JS, Petrushkin H, Testi I, et al
    UVESCREEN1: A randomised feasibility study of imaging-based uveitis screening for children with juvenile idiopathic arthritis- Study Protocol.
    PLoS One. 2025;20:e0316410.
    PubMed     Abstract available


  93. MAMELI C, Valsecchi C, Cereda D, Scarioni S, et al
    Type 1 diabetes incidence during COVID-19 pandemic has not been influenced by COVID-19 vaccination in northern Italy region, Lombardy.
    PLoS One. 2025;20:e0316340.
    PubMed     Abstract available


  94. MCCARTHY EM, Dinneen SF, Byrne M, Morrissey EC, et al
    Perceptions and experiences of young adults and their healthcare team of the D1 Now type 1 diabetes intervention.
    PLoS One. 2025;20:e0316345.
    PubMed     Abstract available


  95. COSTA V, Aluan K, Schiavetti I, Bason C, et al
    Study protocol: Exploratory trial of Forza, an osmotin-based nutraceutical as adjuvant for the treatment of progressive multiple sclerosis.
    PLoS One. 2025;20:e0311214.
    PubMed     Abstract available


  96. KHDAIR SI, Al-Khareisha L, Abusara OH, Hammad AM, et al
    HLA-class II genes association with multiple sclerosis: An immunogenetic prediction among multiple sclerosis Jordanian patients.
    PLoS One. 2025;20:e0318824.
    PubMed     Abstract available


  97. DE DIOS PEREZ B, Booth V, das Nair R, Evangelou N, et al
    Vocational rehabilitation for people with multiple sclerosis in the national health service of the United Kingdom: A realist evaluation.
    PLoS One. 2025;20:e0319287.
    PubMed     Abstract available


  98. TATULASHVILI S, Dreves B, Cosson E, Meyer L, et al
    First validity testing of GluciQuizz, a French self-questionnaire evaluating carb-counting for patients with type 1 diabetes.
    PLoS One. 2025;20:e0318746.
    PubMed     Abstract available


  99. CHEN S, Cui X, Chen Y, Guo X, et al
    Biologic therapies for the treatment of large vessel vasculitis: A systematic review and meta-analysis.
    PLoS One. 2025;20:e0314566.
    PubMed     Abstract available


  100. ISLAM MZ, Zimmerman S, Lindahl A, Weidanz J, et al
    Single-cell RNA-seq reveals disease-specific CD8+ T cell clonal expansion and a high frequency of transcriptionally distinct double-negative T cells in diabetic NOD mice.
    PLoS One. 2025;20:e0317987.
    PubMed     Abstract available


  101. SHIMIZU S, Tanaka A, Matsuyama N, Kinoshita F, et al
    Randomised, double-blind study to evaluate the efficacy of rituximab in the treatment of idiopathic membranous nephropathy: A clinical trial protocol.
    PLoS One. 2025;20:e0320070.
    PubMed     Abstract available


  102. RUSSO JS, Mahoney T, Kokorin K, Reynolds A, et al
    Towards developing brain-computer interfaces for people with Multiple Sclerosis.
    PLoS One. 2025;20:e0319811.
    PubMed     Abstract available


  103. ETEMADIFAR M, Shoeib S, Salari M, Etemadifar M, et al
    Gynecologic health of women with multiple sclerosis: An overview on the current status and findings of Pap tests in a low-income setting.
    PLoS One. 2025;20:e0320069.
    PubMed     Abstract available


  104. WANG S, Ka M, Wu W
    Does hydroxychloroquine reduce the risk of infection in patients with systemic lupus erythematosus? a systematic review and meta-analysis.
    PLoS One. 2025;20:e0320353.
    PubMed     Abstract available


  105. REN Y, Chen W, Lin Y, Wang Z, et al
    Identification of glucocorticoid-related genes in systemic lupus erythematosus using bioinformatics analysis and machine learning.
    PLoS One. 2025;20:e0319737.
    PubMed     Abstract available


  106. SALAME G, Hakim V, Dagher C, Daou RM, et al
    Immunotherapy as a treatment for type 1 diabetes mellitus in children and young adults: A comprehensive systematic review and meta-analysis.
    PLoS One. 2025;20:e0321727.
    PubMed     Abstract available


  107. GOETTFRIED E, Barket R, Hershman R, Delazer M, et al
    Face exploration, emotion recognition, and emotional enhancement of memory in relapsing-remitting multiple sclerosis.
    PLoS One. 2025;20:e0319967.
    PubMed     Abstract available


  108. SU Y, Li X, Wu PD, Zhang YL, et al
    The Association between PTPN22 SNPs and susceptibility to type 1 diabetes: An updated meta-analysis.
    PLoS One. 2025;20:e0321624.
    PubMed     Abstract available


  109. SCHLAEGER S, Muhlau M, Gilbert G, Vavasour I, et al
    Sensitivity of multi-parametric quantitative magnetic resonance imaging for multiple sclerosis pathology.
    PLoS One. 2025;20:e0318415.
    PubMed     Abstract available


  110. WU Q, Chen Y, Shen M, Cai Y, et al
    Moderate to severe chronic arteriolar lesions is an independent risk factor for adverse renal outcomes in IgA nephropathy.
    PLoS One. 2025;20:e0320635.
    PubMed     Abstract available


  111. ZANGENEH Z, Rostamian M, Motamedi H, Alvandi A, et al
    The potential effectiveness of probiotics in reducing multiple sclerosis progression in preclinical and clinical studies: A worldwide systematic review and meta-analysis.
    PLoS One. 2025;20:e0319755.
    PubMed     Abstract available


  112. GUTIERREZ-GUTIERREZ G, Gomez-Ballesteros R, Sotoca J, Ares A, et al
    Assessing therapeutic decisions in generalized myasthenia gravis: Study protocol.
    PLoS One. 2025;20:e0322168.
    PubMed     Abstract available


  113. YIN J, Hou Y, Wang C, Qin C, et al
    Clinical outcomes of baricitinib in patients with systemic lupus erythematosus: Pooled analysis of SLE-BRAVE-I and SLE-BRAVE-II trials.
    PLoS One. 2025;20:e0320179.
    PubMed     Abstract available


  114. HE S, Nie H, Yin X, Zhong Z, et al
    Identification of key extracellular proteins as the potential biomarkers in thyroid eye disease.
    PLoS One. 2025;20:e0322415.
    PubMed     Abstract available


  115. MENG H, Wang S, Gu L, Wang Y, et al
    Potential drug targets for Neuromyelitis optica spectrum disorders (NMOSD): A Mendelian randomization analysis.
    PLoS One. 2025;20:e0322098.
    PubMed     Abstract available


  116. ALAZWARI A, Tafakori L, Johnstone A, Abdollahian M, et al
    Modeling the number of new cases of childhood type 1 diabetes using Poisson regression and machine learning methods; a case study in Saudi Arabia.
    PLoS One. 2025;20:e0321480.
    PubMed     Abstract available


  117. ALMOMANI BA, Elayyan RN, Al-Shatnawi SF
    Type 1 diabetes mellitus in children: Patient reported outcomes.
    PLoS One. 2025;20:e0322882.
    PubMed     Abstract available


  118. MCKECHNIE V, Avari P, Eng PC, Unsworth R, et al
    The experiences of high-risk young adults with type 1 diabetes transitioning to real-time continuous glucose monitoring - A thematic analysis.
    PLoS One. 2025;20:e0320702.
    PubMed     Abstract available


  119. HERMINE O, Gros L, Tran TA, Loussaief L, et al
    Tyrosine kinase inhibitor, masitinib, limits neuronal damage, as measured by serum neurofilament light chain concentration in a model of neuroimmune-driven neurodegenerative disease.
    PLoS One. 2025;20:e0322199.
    PubMed     Abstract available


  120. MITTAL R, McKenna K, Lemos JRN, Juneja S, et al
    Therapeutic potential of anti-thymocyte globulin in type 1 diabetes: A systematic review.
    PLoS One. 2025;20:e0323642.
    PubMed     Abstract available


  121. GUAN X, Liu W, Gao T, Jin W, et al
    Anti-beta2GPI/beta2GPI complex promotes thrombosis by activating the P2Y2/MAPKs pathway to increase human neutrophil peptides.
    PLoS One. 2025;20:e0322447.
    PubMed     Abstract available


  122. OMER N, Wilczynski E, Zlotzover S, Helft C, et al
    Validation of a data-driven multicomponent T2 analysis for quantifying myelin content in the cuprizone mouse model of multiple sclerosis.
    PLoS One. 2025;20:e0323614.
    PubMed     Abstract available


  123. YOUNG G, Nguyen VS, Howlett-Prieto Q, Abuaf AF, et al
    Validation of retroactively derived T1 relaxation values from 3D T1-weighted images with clinical and MRI measures of disability in multiple sclerosis.
    PLoS One. 2025;20:e0323898.
    PubMed     Abstract available


  124. OZTURK HK, Slanar O, Michalickova D
    Safety and efficacy of antigen-specific therapeutic approaches for multiple sclerosis: Systematic review.
    PLoS One. 2025;20:e0320814.
    PubMed     Abstract available


  125. LAI L, Wu C, Li X, Rong Y, et al
    Urinary MCP-1 and VCAM-1 as non-invasive biomarkers for the diagnosis and activity assessment of lupus nephritis.
    PLoS One. 2025;20:e0323334.
    PubMed     Abstract available


  126. KRULL F, Hosseini S, Bleyer M, Brenig B, et al
    Findings from transcriptomics and immunohistochemistry indicate an autoimmune disease targeting brainstem inhibitory interneurons in bovine spastic paresis.
    PLoS One. 2025;20:e0324633.
    PubMed     Abstract available


  127. MAKHLOUF Y, Ayed HB, Miladi S, Boussaa H, et al
    Effect of biologic treatments on growth in children with juvenile idiopathic arthritis: A systematic review.
    PLoS One. 2025;20:e0324440.
    PubMed     Abstract available


  128. RAINA M, Shah R, Hu J, Pember B, et al
    The global health burden of pediatric chronic kidney disease: An analysis of the Global Burden of Disease database from 1990 to 2021.
    PLoS One. 2025;20:e0323257.
    PubMed     Abstract available


  129. JARAB AS, Al-Qerem WA, Alqudah S, Alzoubi KH, et al
    Insulin-self administration among individuals with diabetes: Implications for improved practices.
    PLoS One. 2025;20:e0324846.
    PubMed     Abstract available


  130. WULLER S, Singer NG, Lewis C, Karlson EW, et al
    Severity of acute SARS-CoV-2 infection and risk of new-onset autoimmune disease: A RECOVER initiative study in nationwide U.S. cohorts.
    PLoS One. 2025;20:e0324513.
    PubMed     Abstract available


  131. ANGENETE OW, Haustreis J, Aune LK, Lundestad A, et al
    Children as controls in research; The voice of the volunteer.
    PLoS One. 2025;20:e0325069.
    PubMed     Abstract available


  132. JEYABALAN A, Jhaveri KD, Bunke M, Briggs JA, et al
    Clinical study outcomes in IgA nephropathy: A systematic literature review and narrative synthesis.
    PLoS One. 2025;20:e0323530.
    PubMed     Abstract available


  133. JIANG W, Peng X, Dong L, Wu L, et al
    Predictors of neuropsychiatric manifestations in pediatric patients with lupus.
    PLoS One. 2025;20:e0325915.
    PubMed     Abstract available


  134. BLOIS SL, Cuq BY, Bienzle D
    Lymphocyte immunophenotype in dogs with immune-mediated hematologic disease.
    PLoS One. 2025;20:e0326341.
    PubMed     Abstract available


  135. DE DIOS PEREZ B, Kendrick D, das Nair R, Evangelou N, et al
    Optimising access to vocational rehabilitation through multiple sclerosis charities: Protocol for a feasibility randomised controlled trial.
    PLoS One. 2025;20:e0325570.
    PubMed     Abstract available


  136. BOZZI S, Umarje S, Hawaldar K, Tyma J, et al
    Prevalence and incidence of primary autoimmune hemolytic anemia and cold agglutinin disease in the United States, 2016-2023.
    PLoS One. 2025;20:e0323843.
    PubMed     Abstract available


  137. MOHAMED YM, Mancera J, Brandenberg A, Fischli S, et al
    Personalized machine learning models for noninvasive hypoglycemia detection in people with type 1 diabetes using a smartwatch: Insights into feature importance during waking and sleeping times.
    PLoS One. 2025;20:e0325956.
    PubMed     Abstract available


  138. MARTIN-AVILA J, Rodriguez-Jimenez E, Valero-Moreno S, Gil-Gomez JA, et al
    Intervention through an intelligent technological platform for socio-emotional development and health promotion in adolescents with Type 1 Diabetes Mellitus (emoTICare): A study protocol for randomized controlled trial.
    PLoS One. 2025;20:e0325763.
    PubMed     Abstract available


  139. CARAZO A, Paclikova M, Fadraersada J, Alva-Gallegos R, et al
    Type 1 diabetes mellitus patients had lower total vitamin K levels and increased sensitivity to direct anticoagulants.
    PLoS One. 2025;20:e0326580.
    PubMed     Abstract available


  140. TAKAHASHI K, Takeishi C, Tsutsumi C, Nakao T, et al
    Exploring the relationship between self-care agency and quality of life in adults with diabetes: A cross-sectional study.
    PLoS One. 2025;20:e0326783.
    PubMed     Abstract available


  141. WANG K, Xu P, Lu J, Ji X, et al
    Circadian rhythm genes and immune cell infiltration in myasthenia gravis: A comprehensive analysis.
    PLoS One. 2025;20:e0327829.
    PubMed     Abstract available


  142. GONG X, Xue X, Gao R, Feng S, et al
    Application of telemedicine in fatigue management for patients with multiple sclerosis: A scoping review.
    PLoS One. 2025;20:e0327563.
    PubMed     Abstract available


  143. MOTOKI Y, Kaneshige R, Fujieda Y, Oku K, et al
    A preliminary report on the feasibility of regression-based alignment of diagnostic thresholds for harmonized use of international classification criteria for antiphospholipid syndrome.
    PLoS One. 2025;20:e0328229.
    PubMed     Abstract available


  144. LIM J, Kim YJ, Kim S, Shim JH, et al
    Impact of metabolic dysfunction-associated steatotic liver disease on hepatocellular carcinoma risk in autoimmune hepatitis.
    PLoS One. 2025;20:e0325066.
    PubMed     Abstract available


  145. HO MKH, Santhireswaran A, Gomes T, Mamdani M, et al
    Comparative effectiveness and safety of insulin reference biologics versus biosimilars for types 1 and 2 diabetes mellitus: Protocol for a systematic review of real-world studies.
    PLoS One. 2025;20:e0329299.
    PubMed     Abstract available


  146. CARR ALJ, Shah R, Marfil-Garza BA, Lam A, et al
    Sequential islet transplants for type 1 diabetes are not associated with sustained or cumulative increases in hepatic portal venous pressure.
    PLoS One. 2025;20:e0329074.
    PubMed     Abstract available


  147. ATTAR A, Alshaikh H, Alharbi G, Aletani T, et al
    Outcomes of myasthenia gravis patients admitted to the Intensive Care Unit: Experience from a tertiary care center in Saudi Arabia.
    PLoS One. 2025;20:e0328648.
    PubMed     Abstract available


  148. MIRMOSAYYEB O, Vaheb S, Afshari-Safavi A, Shaygannejad A, et al
    Long-term effects of air pollution on the incidence and progression of multiple sclerosis: A population cohort study in Isfahan, Iran.
    PLoS One. 2025;20:e0327635.
    PubMed     Abstract available


  149. RASMUSSEN MGB, Just-Ostergaard E, Stidsen JV, Willaing I, et al
    What is the impact of structural changes in society on diabetes self-management and trajectories of HbA1c? A cohort study before, during and after the COVID-19 pandemic in people with diabetes treated at outpatient clinics.
    PLoS One. 2025;20:e0329394.
    PubMed     Abstract available


  150. ZHOU J, Zhang Z, Zhou K, Zhou L, et al
    PLA2R1 and HLA-DQA1 SNP in patients with primary membranous nephropathy.
    PLoS One. 2025;20:e0328234.
    PubMed     Abstract available


  151. AKAMINE H, Uzawa A, Kuwabara S, Suzuki S, et al
    Predicting achievement of clinical goals using machine learning in myasthenia gravis.
    PLoS One. 2025;20:e0330044.
    PubMed     Abstract available


  152. VINCENTINI O, Pricci F, Silano M, Agrimi U, et al
    Study protocol of D1Ce Screen: A pilot project of the Italian national screening program for type 1 diabetes and coeliac disease in the paediatric population.
    PLoS One. 2025;20:e0328624.
    PubMed     Abstract available


  153. URASHIMA K, Ichinose K, Ishimaru H, Kumazaki H, et al
    Novel imaging diagnosis of neuropsychiatric systemic lupus erythematosus using topological data analysis: A retrospective study.
    PLoS One. 2025;20:e0329859.
    PubMed     Abstract available


  154. NGUYEN MTT, Le MH, Vu MN, Baumann K, et al
    Clinical and quality of life improvement after bilastine treatment among patients with autoimmune chronic spontaneous urticaria.
    PLoS One. 2025;20:e0326445.
    PubMed     Abstract available


  155. GOEZ-MORA JE, Arbelaez-Cordoba N, Balcazar-Morales N, Rivadeneira PS, et al
    Validation in diabetic rats of a fully automated insulin delivery system based on impulsive offset-free MPC control.
    PLoS One. 2025;20:e0330121.
    PubMed     Abstract available


  156. AL-EITAN L, Darabseh S
    VDR gene variants FokI and ApaI: Factors associated with susceptibility to multiple sclerosis.
    PLoS One. 2025;20:e0332473.
    PubMed     Abstract available


  157. LI L, Olcer M, Wang Z, Song Y, et al
    IFN-beta therapy rescues dysregulated IFN-stimulated proteins, serum cytokines, and neurotrophic factors in multiple sclerosis: Multiplex analysis of short-term and long-term IFN responses.
    PLoS One. 2025;20:e0330867.
    PubMed     Abstract available


  158. NAKHOUL L, Nakhoul T, Abi Azar M, Harb F, et al
    The efficacy of DPP IV inhibitors as adjunct therapy for patients with auto-immune Diabetes: A systematic review and meta-analysis.
    PLoS One. 2025;20:e0332191.
    PubMed     Abstract available


  159. SURENDRANATH A, Damani R, Muddasani A, Gupta AK, et al
    Comparing Guillain-Barre syndrome outcomes between rural and urban hospitals in the United States: A retrospective cohort study.
    PLoS One. 2025;20:e0333403.
    PubMed     Abstract available


  160. AL-EITAN L, Ataa A
    Investigating genetic links of vitamin D metabolism pathway genes (CYP2R1, CYP27B1, CYP24A1, and DBP) in Multiple Sclerosis patients.
    PLoS One. 2025;20:e0333924.
    PubMed     Abstract available


  161. YOSHIKAWA H, Adachi Y, Nakamura Y, Kuriyama N, et al
    Comparative study of Japanese nationwide epidemiological studies of myasthenia gravis using datasets of 2006 and 2018.
    PLoS One. 2025;20:e0334041.
    PubMed     Abstract available


  162. CAMBIER A, Da Silva J, Bex J, Canesi F, et al
    Blockade of mTOR ameliorates IgA nephropathy by correcting CD89 and CD71 dysfunctions in humanized mice.
    PLoS One. 2025;20:e0318581.
    PubMed     Abstract available


  163. SOLARI A, De Panfilis L, Zagarella RM, Ghirotto L, et al
    Advance care planning in multiple sclerosis (ConCure-SM): A multicenter single-arm pilot and feasibility study.
    PLoS One. 2025;20:e0331220.
    PubMed     Abstract available


  164. MOREN J, Persson B, Sorman A, Lundkvist A, et al
    Low frequency of N-methyl-D-aspartate receptor autoimmunity in tick-borne encephalitis.
    PLoS One. 2025;20:e0334438.
    PubMed     Abstract available


  165. OGUZ-AKARSU E, Lazrak SEH, Sigirli D, Gullu G, et al
    Myasthenia gravis and autoimmune overlap: Prognostic insight.
    PLoS One. 2025;20:e0334434.
    PubMed     Abstract available


  166. FRAGOZO-RAMOS MC, Schenker G, Hepprich M, Gallo-Villegas J, et al
    GIP/GLP-1RA as adjunctive to automated insulin delivery in adults with Type 1 diabetes (the AID-JUNCT trial): Study protocol for a prospective, randomized, clinical trial.
    PLoS One. 2025;20:e0335060.
    PubMed     Abstract available


  167. LTEIF MR, Kalot J, Jaouni ME, Khoury SJ, et al
    E-health literacy levels of multiple sclerosis patients in Lebanon.
    PLoS One. 2025;20:e0335084.
    PubMed     Abstract available


  168. GRIMA AA, Hiraki LT, Bolotin S, Paterson AD, et al
    New onset autoimmune disease following a SARS-CoV-2 infection: A systematic review protocol.
    PLoS One. 2025;20:e0335766.
    PubMed     Abstract available


  169. ALJOHANI N, Forbes A, Daqrashawi G, Due-Christensen M, et al
    'You decided I am old enough for the transition, but not old enough to have a say?': Exploring young people's, parents', and healthcare providers' views and experiences of Type 1 Diabetes paediatric to adult healthcare transition in Saudi Arabia.
    PLoS One. 2025;20:e0335347.
    PubMed     Abstract available


  170. ZGLEJC-WASZAK K, Jastrzebski JP, Wojtkiewicz J, Pidsudko Z, et al
    Novel insights into neuropathy: The impact of prolonged hyperglycemia on long non-coding RNA expression.
    PLoS One. 2025;20:e0334245.
    PubMed     Abstract available


  171. JIANG L, Jin Y, Han Y, Fu J, et al
    TRIM37-mediated stabilization of PEX5 via monoubiquitination attenuates oxidative stress and demyelination in multiple sclerosis insights from EAE and LPC-induced experimental models.
    PLoS One. 2025;20:e0335198.
    PubMed     Abstract available


  172. YANG MK, Ha SJ, Sa HS
    Comparison of volumetric responses to different corticosteroid administration methods in IgG4-related ophthalmic disease.
    PLoS One. 2025;20:e0332392.
    PubMed     Abstract available


  173. JIANG M, Wang P, Yu D, Guo P, et al
    Network pharmacology and experiments verify the effect of triptolide on extraocular muscle fibrosis.
    PLoS One. 2025;20:e0336487.
    PubMed     Abstract available


  174. HUNDAHL A, Jespersen LN, Sildorf SM, Lindkvist EB, et al
    Fear of hypoglycemia and its association with well-being, metabolic outcomes, and psychological health: A cross-sectional study in Danish adolescents with type 1 diabetes.
    PLoS One. 2025;20:e0334243.
    PubMed     Abstract available


  175. FAHY A, Coote S, Maguire R
    Evaluation of MoveSmart MS - an online structured exercise, Social Cognitive Theory-based behavioural coaching and peer support programme - on anxiety in multiple sclerosis.
    PLoS One. 2025;20:e0336493.
    PubMed     Abstract available


  176. SURESHKUMAR A, Simpson R, Bayley M, Kastner M, et al
    The use of implementation strategies to promote the uptake of psychological therapies among people with multiple sclerosis: A scoping review protocol.
    PLoS One. 2025;20:e0337105.
    PubMed     Abstract available


  177. TABATABAEE S, Eissazade N, Mirzaasgari Z, Tabatabaee SM, et al
    Trans-orbital sonography of the optic nerve in multiple sclerosis.
    PLoS One. 2025;20:e0336564.
    PubMed     Abstract available


  178. SALMAN F, Bergsland N, Dwyer MG, Reeves JA, et al
    Impact of processing and analysis methodology on thalamic susceptibility assessment in multiple sclerosis.
    PLoS One. 2025;20:e0332478.
    PubMed     Abstract available


  179. CHERO-SANDOVAL L, Higuera-Gomez A, de Cuevillas B, Castejon R, et al
    Body mass index distinctly modulates the associations between Alistipes and CRP/IL-6 in metabolic and lupus inflammatory features.
    PLoS One. 2025;20:e0335452.
    PubMed     Abstract available


  180. FISHER SS, Lindaas A, Muthuri SG, Lloyd PC, et al
    Risk of neurologic or immune-mediated adverse events after COVID-19 diagnosis in the United States.
    PLoS One. 2025;20:e0333704.
    PubMed     Abstract available


  181. SAMA SR, Gore R, Bauer AZ, Garber L, et al
    Autoimmune diseases as pre-existing conditions and sequelae of post COVID-19 condition in a Massachusetts community based observational study of COVID-19 patients.
    PLoS One. 2025;20:e0337848.
    PubMed     Abstract available


  182. BEVERLY EA, Miller S, Schmidtgesling L, Whistler K, et al
    How coping styles moderate the relationship between diabetes distress and self-care in adults with diabetes in Appalachian Ohio: A cross-sectional survey study.
    PLoS One. 2025;20:e0337481.
    PubMed     Abstract available


  183. LEE GM, Lee MJ, Kim N, Choung H, et al
    Photographic evaluation of clinical activity score in thyroid eye disease.
    PLoS One. 2025;20:e0337597.
    PubMed     Abstract available


  184. KREITER D, Franken N, Bouweriks D, Knippenberg S, et al
    Spinal cord lesions in relapsing-remitting multiple sclerosis: Prognostic value of intrathecal production of immunoglobulins.
    PLoS One. 2025;20:e0337515.
    PubMed     Abstract available


  185. DURON L, Chazal T, Sene T, Savatovsky J, et al
    Fast-track pathway for giant cell arteritis: Improved visual outcomes and reduced healthcare costs.
    PLoS One. 2025;20:e0338397.
    PubMed     Abstract available


  186. VESTITO L, Schenone C, Casazza F, Modenesi R, et al
    Impact of anodal tDCS and virtual reality on cognitive dysfunction in patients with Multiple Sclerosis: Protocol of a double blind, randomized, prospective, controlled study.
    PLoS One. 2025;20:e0337405.
    PubMed     Abstract available


  187. CHI G, Che Y, Pei J, Li X, et al
    Decoding the distinct immune landscape and possible regulatory mechanisms of autoimmune hepatitis through integrated single-cell and bulk RNA sequencing.
    PLoS One. 2025;20:e0335605.
    PubMed     Abstract available


  188. LI Y, Liu B, Hu G, Zhou T, et al
    Human umbilical cord-derived mesenchymal stem cells alleviate autoimmune hepatitis by inhibiting hepatic ferroptosis.
    PLoS One. 2025;20:e0337060.
    PubMed     Abstract available


  189. VAUTHIER JC, Choley L, Kabuth B
    Chronic illness and extreme performance: Type 1 diabetes in ultra-endurance.
    PLoS One. 2025;20:e0338637.
    PubMed     Abstract available


  190. HE Z, Li W, Huang X, Ma S, et al
    Apathy in patients with Neuromyelitis Optica Spectrum Disorder.
    PLoS One. 2025;20:e0339479.
    PubMed     Abstract available


  191. BUCHKA S, Havla J, On BI, Rehms R, et al
    Individual-level surrogacy of MRI lesions for disease severity in RRMS: Methods to quantify predictive power and their application to longitudinal data from recent trials.
    PLoS One. 2025;20:e0337893.
    PubMed     Abstract available


    January 2024
  192. XUE H, Zeng L, He H, Xu D, et al
    Effects of acupuncture treatment for myasthenia gravis: A systematic review and meta-analysis.
    PLoS One. 2024;19:e0291685.
    PubMed     Abstract available


  193. EKMAN L, Dahlin LB, Andersson GS, Lindholm E, et al
    Diagnostic contribution of multi-frequency vibrometry to detection of peripheral neuropathy in type 1 diabetes mellitus compared with nerve conduction studies.
    PLoS One. 2024;19:e0296661.
    PubMed     Abstract available


  194. MORCIANO C, Spila Alegiani S, Menniti Ippolito F, Belleudi V, et al
    Post-marketing active surveillance of Guillain Barre Syndrome following COVID-19 vaccination in persons aged >/=12 years in Italy: A multi-database self-controlled case series study.
    PLoS One. 2024;19:e0290879.
    PubMed     Abstract available


  195. DASGUPTA SK, Gollamudi J, Rivera S, Poche RA, et al
    beta2-glycoprotein I promotes the clearance of circulating mitochondria.
    PLoS One. 2024;19:e0293304.
    PubMed     Abstract available


  196. TOLF A, Gauffin H, Burman J, Landtblom AM, et al
    Experiences of being treated with autologous haematopoietic stem cell transplantation for aggressive multiple sclerosis: A qualitative interview study.
    PLoS One. 2024;19:e0297573.
    PubMed     Abstract available


  197. YANG H, Chen Z, Huang J, Li S, et al
    AWD-stacking: An enhanced ensemble learning model for predicting glucose levels.
    PLoS One. 2024;19:e0291594.
    PubMed     Abstract available


  198. DADVAR A, Jameie M, Azizmohammad Looha M, Parsaei M, et al
    Potential efficacy of caffeine ingestion on balance and mobility in patients with multiple sclerosis: Preliminary evidence from a single-arm pilot clinical trial.
    PLoS One. 2024;19:e0297235.
    PubMed     Abstract available


  199. JAKA S, Singh S, Vashist S, Pokhrel S, et al
    Pediatric anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis: Exploring psychosis, related risk factors, and hospital outcomes in a nationwide inpatient sample: A cross-sectional study.
    PLoS One. 2024;19:e0296870.
    PubMed     Abstract available


  200. MITTAL R, McKenna K, Keith G, Lemos JRN, et al
    A systematic review of the association of Type I diabetes with sensorineural hearing loss.
    PLoS One. 2024;19:e0298457.
    PubMed     Abstract available


  201. SHEMIRANI F, Pingel WR, Titcomb TJ, Salari-Moghaddam A, et al
    The effect of dietary interventions on inflammatory biomarkers among people with multiple sclerosis: A protocol for systematic review and meta-analysis of randomized controlled trials.
    PLoS One. 2024;19:e0297510.
    PubMed     Abstract available


  202. JEONG HS, Chun BC
    COVID-19 vaccine safety: Background incidence rates of anaphylaxis, myocarditis, pericarditis, Guillain-Barre Syndrome, and mortality in South Korea using a nationwide population-based cohort study.
    PLoS One. 2024;19:e0297902.
    PubMed     Abstract available


  203. LIU X, Xue J, Li T, Wu Q, et al
    Quantitative detection and prognostic value of antibodies against M-type phospholipase A2 receptor and its cysteine-rich ricin domain and C-type lectin domains 1 and 6-7-8 in patients with idiopathic membranous nephropathy.
    PLoS One. 2024;19:e0298269.
    PubMed     Abstract available


  204. SMUDJA M, Milenkovic T, Minakovic I, Zdravkovic V, et al
    Self-care activities in pediatric patients with type 1 diabetes mellitus.
    PLoS One. 2024;19:e0300055.
    PubMed     Abstract available


  205. TRAN TT, Nguyen TN, Dauvilliers Y, Liblau R, et al
    Absence of specific autoantibodies in patients with narcolepsy type 1 as indicated by an unbiased random peptide-displayed phage screening.
    PLoS One. 2024;19:e0297625.
    PubMed     Abstract available


  206. JOZEF M, Locatelli I, Brecl Jakob G, Savsek L, et al
    Psychometric evaluation of the 5-item Medication Adherence Report Scale questionnaire in persons with multiple sclerosis.
    PLoS One. 2024;19:e0294116.
    PubMed     Abstract available


  207. LIU P, Luo J, Zhao L, Fu Q, et al
    Causal relationship between several autoimmune diseases and renal malignancies: A two-sample mendelian randomization study.
    PLoS One. 2024;19:e0297861.
    PubMed     Abstract available


  208. FLOYD L, Dhaygude A, Mitra S, Rowland C, et al
    Developing a disease-specific patient reported outcome measure to enhance understanding of the lived experiences of ANCA associated vasculitis: A protocol paper.
    PLoS One. 2024;19:e0298796.
    PubMed     Abstract available


  209. LIU Z, Fan T, Mo X, Kan J, et al
    Association between multiple sclerosis and cancer risk: A two-sample Mendelian randomization study.
    PLoS One. 2024;19:e0298271.
    PubMed     Abstract available


  210. CARATIS F, Opielka M, Hausmann M, Velasco-Estevez M, et al
    The proton-sensing receptors TDAG8 and GPR4 are differentially expressed in human and mouse oligodendrocytes: Exploring their role in neuroinflammation and multiple sclerosis.
    PLoS One. 2024;19:e0283060.
    PubMed     Abstract available


  211. LEREIM RR, Nytrova P, Guldbrandsen A, Havrdova EK, et al
    Natalizumab promotes anti-inflammatory and repair effects in multiple sclerosis.
    PLoS One. 2024;19:e0300914.
    PubMed     Abstract available


  212. BRNABIC AJM, Curtis SE, Johnston JA, Lo A, et al
    Incidence of type 2 diabetes, cardiovascular disease and chronic kidney disease in patients with multiple sclerosis initiating disease-modifying therapies: Retrospective cohort study using a frequentist model averaging statistical framework.
    PLoS One. 2024;19:e0300708.
    PubMed     Abstract available


  213. IMRAISH A, Abu Thiab T, Alsalem M, Dahbour S, et al
    The neuroprotective effect of human primary astrocytes in multiple sclerosis: In vitro model.
    PLoS One. 2024;19:e0300203.
    PubMed     Abstract available


  214. ESIASON DC, Ciesinski N, Nurse CN, Erler W, et al
    The psychological burden of NMOSD - a mixed method study of patients and caregivers.
    PLoS One. 2024;19:e0300777.
    PubMed     Abstract available


  215. KAMPAITE A, Gustafsson R, York EN, Foley P, et al
    Brain connectivity changes underlying depression and fatigue in relapsing-remitting multiple sclerosis: A systematic review.
    PLoS One. 2024;19:e0299634.
    PubMed     Abstract available


  216. MA J, Xing J, Zhang Y, Liu G, et al
    Efficacy and safety of biologic agents for IgA nephropathy: A protocol for systematic review and meta-analysis.
    PLoS One. 2024;19:e0298732.
    PubMed     Abstract available


  217. JANSSENS N, Van Wilder L, Van Hecke A, Van Hoorenbeeck K, et al
    COCCOS study: Developing a transition program for adolescents with chronic conditions using Experience-Based Co-Design. A study protocol.
    PLoS One. 2024;19:e0298571.
    PubMed     Abstract available


  218. MEDINA-RAMIREZ SA, Soriano-Moreno DR, Tuco KG, Castro-Diaz SD, et al
    Prevalence and incidence of diabetic retinopathy in patients with diabetes of Latin America and the Caribbean: A systematic review and meta-analysis.
    PLoS One. 2024;19:e0296998.
    PubMed     Abstract available


  219. YAGHOOBPOOR S, Fathi M, Vakili K, Sayehmiri F, et al
    Insulin-like growth factor-1 (IGF-1) levels in multiple sclerosis patients: A systematic review and meta-analysis.
    PLoS One. 2024;19:e0297091.
    PubMed     Abstract available


  220. LOMER NB, Asalemi KA, Saberi A, Sarlak K, et al
    Predictors of multiple sclerosis progression: A systematic review of conventional magnetic resonance imaging studies.
    PLoS One. 2024;19:e0300415.
    PubMed     Abstract available


  221. LI H, Huntington S, Gross C, Wang SY, et al
    Immunotherapy utilization patterns in patients with advanced cancer and autoimmune disease.
    PLoS One. 2024;19:e0300789.
    PubMed     Abstract available


  222. DE RIDDER F, Braspenning R, Ordonez JS, Klarenbeek G, et al
    Early feasibility study with an implantable near-infrared spectroscopy sensor for glucose, ketones, lactate and ethanol.
    PLoS One. 2024;19:e0301041.
    PubMed     Abstract available


  223. SCAGNELLATO L, Cozzi G, Prosepe I, Lorenzin M, et al
    Relapses of juvenile idiopathic arthritis in adulthood: A monocentric experience.
    PLoS One. 2024;19:e0298679.
    PubMed     Abstract available


  224. SVENSSON AK, Dahlin LB, Rydberg M, Perez R, et al
    Surgery for carpal tunnel syndrome in patients with and without diabetes-Is there a difference in the frequency of surgical procedures?
    PLoS One. 2024;19:e0302219.
    PubMed     Abstract available


  225. ZHOU K, Zhou J, Zhou L, Xue J, et al
    Predictive value of the domain specific PLA2R antibodies for clinical remission in patients with primary membranous nephropathy: A retrospective study.
    PLoS One. 2024;19:e0302100.
    PubMed     Abstract available


  226. UEDA H, Joh K, Ueda Y, Marumoto H, et al
    Accelerated involution of germinal center in palatine tonsils in IgA nephropathy.
    PLoS One. 2024;19:e0301853.
    PubMed     Abstract available


  227. LEE YH, Song GG
    Platelet-to-lymphocyte ratio as a biomarker of systemic inflammation in systemic lupus erythematosus: A meta-analysis and systematic review.
    PLoS One. 2024;19:e0303665.
    PubMed     Abstract available


  228. ZHAI Y, Tian H, Zhang W, Sun S, et al
    Genome-wide analysis of long noncoding RNAs as cis-acting regulators of transcription factor-encoding genes in IgA nephropathy.
    PLoS One. 2024;19:e0304301.
    PubMed     Abstract available


  229. CREMER T, Hoelen H, van de Weijer ML, Janssen GM, et al
    Proinsulin degradation and presentation of a proinsulin B-chain autoantigen involves ER-associated protein degradation (ERAD)-enzyme UBE2G2.
    PLoS One. 2024;19:e0287877.
    PubMed     Abstract available


  230. COBB J, Rawson J, Gonzalez N, Orr C, et al
    Reversal of diabetes by an oral Salmonella-based vaccine in acute and progressive diabetes in NOD mice.
    PLoS One. 2024;19:e0303863.
    PubMed     Abstract available


  231. REBALKA IA, Noguchi KS, Bulyovsky KR, Badour MI, et al
    Targeting skeletal muscle health with exercise in people with type 1 diabetes: A protocol for HOMET1D, a prospective observational trial with matched controls.
    PLoS One. 2024;19:e0303448.
    PubMed     Abstract available


  232. JEONG C, Baek H, Bae J, Hwang N, et al
    Gut microbiome in the Graves' disease: Comparison before and after anti-thyroid drug treatment.
    PLoS One. 2024;19:e0300678.
    PubMed     Abstract available


  233. HARRISON DM, Allette YM, Zeng Y, Cohen A, et al
    Meningeal contrast enhancement in multiple sclerosis: Assessment of field strength, acquisition delay, and clinical relevance.
    PLoS One. 2024;19:e0300298.
    PubMed     Abstract available


  234. DUAN P, Tian S
    Mendelian randomization analyses reveal no genetic causal effects of major adipokines on systemic lupus erythematosus.
    PLoS One. 2024;19:e0301699.
    PubMed     Abstract available


  235. EKELUND C, Dereke J, Nilsson C, Landin-Olsson M, et al
    Are soluble E-selectin, ICAM-1, and VCAM-1 potential predictors for the development of diabetic retinopathy in young adults, 15-34 years of age? A Swedish prospective cohort study.
    PLoS One. 2024;19:e0304173.
    PubMed     Abstract available


  236. BALDASSO BD, Raza SZ, Islam SS, Burry IB, et al
    Disrupted hemodynamic response within dorsolateral prefrontal cortex during cognitive tasks among people with multiple sclerosis-related fatigue.
    PLoS One. 2024;19:e0303211.
    PubMed     Abstract available


  237. BAXTER F, Baillie N, Dover A, Stimson RH, et al
    A cross-sectional questionnaire study: Impaired awareness of hypoglycaemia remains prevalent in adults with type 1 diabetes and is associated with the risk of severe hypoglycaemia.
    PLoS One. 2024;19:e0297601.
    PubMed     Abstract available


  238. STEFANOVIC M, Jovanovic I, Zivkovic M, Stankovic A, et al
    Pathway analysis of peripheral blood CD8+ T cell transcriptome shows differential regulation of sphingolipid signaling in multiple sclerosis and glioblastoma.
    PLoS One. 2024;19:e0305042.
    PubMed     Abstract available


  239. ALMUTAIRI FF
    The feasibility of point shear wave elastography (pSWE) in the assessment of pancreas stiffness in diabetic patients and healthy volunteers.
    PLoS One. 2024;19:e0303098.
    PubMed     Abstract available


  240. CHI G, Pei J, Li X
    Inflammatory bowel disease and risk of autoimmune hepatitis: A univariable and multivariable Mendelian randomization study.
    PLoS One. 2024;19:e0305220.
    PubMed     Abstract available


  241. SERATA EL, Noonan EJ, Petersen KH
    Barriers to USMLE Step-1 accommodations: Students with Type 1 Diabetes.
    PLoS One. 2024;19:e0304784.
    PubMed     Abstract available


  242. HE L, He W
    Clinicopathologic features and outcomes of bilateral lacrimal gland lesions.
    PLoS One. 2024;19:e0305717.
    PubMed     Abstract available


  243. GEBREMESKEL GG, Haile TG, Gebrewahd GT, Hailay A, et al
    Effectiveness of non-pharmacological therapies for chronic pain in people with autoimmune diseases in Africa: A protocol for a systematic review and meta-analysis.
    PLoS One. 2024;19:e0306564.
    PubMed     Abstract available


  244. LI Z, Jia B, Guo Z, Zhang K, et al
    Therapeutic potential of salidroside in type I diabetic erectile dysfunction: Attenuation of oxidative stress and apoptosis via the Nrf2/HO-1 pathway.
    PLoS One. 2024;19:e0306926.
    PubMed     Abstract available


  245. PIKULIN S, Yehezkel I, Moskovitch R
    Enhanced blood glucose levels prediction with a smartwatch.
    PLoS One. 2024;19:e0307136.
    PubMed     Abstract available


  246. SUMIMOTO H, Noda S, Koide H, Douke Y, et al
    Pre-existing autoimmune disease as a risk factor for immune-related adverse events in cancer patients receiving immune checkpoint inhibitors.
    PLoS One. 2024;19:e0306995.
    PubMed     Abstract available


  247. CAMPANIONI S, Veiga C, Prieto-Gonzalez JM, Gonzalez-Novoa JA, et al
    Explainable machine learning on baseline MRI predicts multiple sclerosis trajectory descriptors.
    PLoS One. 2024;19:e0306999.
    PubMed     Abstract available


  248. YAMADA K, Tanabe A, Hashimoto M, Ohsugi M, et al
    A single-center retrospective study on the clinical features of thyrotoxic periodic paralysis.
    PLoS One. 2024;19:e0308076.
    PubMed     Abstract available


  249. WANG YY, Ying HM, Tian F, Qian XL, et al
    Three months use of Hybrid Closed Loop Systems improves glycated hemoglobin levels in adolescents and children with type 1 diabetes: A meta-analysis.
    PLoS One. 2024;19:e0308202.
    PubMed     Abstract available


  250. KIM N, Kim S, Choi JR, Park Y, et al
    Evaluation of autoimmune liver disease antibodies in hepatitis patients.
    PLoS One. 2024;19:e0307285.
    PubMed     Abstract available


  251. LI B, Zhang L, Li Q, Zhang J, et al
    Multiple sclerosis and abnormal spermatozoa: A bidirectional two-sample mendelian randomization study.
    PLoS One. 2024;19:e0308815.
    PubMed     Abstract available


  252. LEE MJ, Verma R, Hamilton BE, Pettersson D, et al
    The utility of orbital imaging in the evaluation of orbital disease.
    PLoS One. 2024;19:e0308528.
    PubMed     Abstract available


  253. CHAIPRASERT A, Han P, Laomettachit T, Ruengjitchatchawalya M, et al
    Network analysis retrieving bioactive compounds from Spirulina (Arthrospira platensis) and their targets related to systemic lupus erythematosus.
    PLoS One. 2024;19:e0309303.
    PubMed     Abstract available


  254. KAKUCS Z, Illes Z, Hayden Z, Berki T, et al
    Osteopontin predicts late-time salience network-related functional connectivity in multiple sclerosis.
    PLoS One. 2024;19:e0309563.
    PubMed     Abstract available


  255. WEISE S, Du Y, Heidemann C, Baumert J, et al
    Diabetes self-management education programs: Results from a nationwide population-based study on characteristics of participants, rating of programs and reasons for non-participation.
    PLoS One. 2024;19:e0310338.
    PubMed     Abstract available


  256. D'ALESSANDRO M, Cameli P, Cotton CV, Lamb JA, et al
    Panel of serum biomarkers for differential diagnosis of idiopathic interstitial lung disease and interstitial lung disease-secondary to systemic autoimmune rheumatic disease.
    PLoS One. 2024;19:e0311357.
    PubMed     Abstract available


  257. CAMBOULIVE L, Grandhomme F, Martin Silva N, Khoy K, et al
    Clinical impact of ceruloplasmin levels at ANCA-associated vasculitis diagnosis.
    PLoS One. 2024;19:e0311678.
    PubMed     Abstract available


  258. MAGEAU A, Geradin C, Sallah K, Papo T, et al
    Risk of systemic lupus erythematosus flare after COVID-19 hospitalization: A matched cohort study.
    PLoS One. 2024;19:e0309316.
    PubMed     Abstract available


  259. BUIANOVA A, Yukina M, Cheranev V, Suchalko O, et al
    Trio-based exome sequencing and high-resolution HLA typing in families of patients with autoimmune adrenal insufficiency and autoimmune polyglandular syndrome.
    PLoS One. 2024;19:e0312335.
    PubMed     Abstract available


  260. SOKRATOUS D, Charalambous CC, Zamba-Papanicolaou E, Michailidou K, et al
    A 12-week in-phase bilateral upper limb exercise protocol promoted neuroplastic and clinical changes in people with relapsing remitting multiple sclerosis: A registered report randomized single-case concurrent multiple baseline study.
    PLoS One. 2024;19:e0299611.
    PubMed     Abstract available


  261. SABOYA-GALINDO P, Mejia-Salgado G, Cifuentes-Gonzalez C, Rodriguez-Rodriguez CA, et al
    Uveitis characteristics and multiple sclerosis phenotype of patients with multiple sclerosis-associated uveitis: A systematic review and meta-analysis.
    PLoS One. 2024;19:e0307455.
    PubMed     Abstract available


  262. KOVACEVIC S, Zdravkovic V, Blagojevic J, Djordjevic S, et al
    Association of variants in AGTR1, ACE, MTHFR genes with microalbuminuria and risk factors for the onset of diabetic nephropathy in adolescents with type 1 diabetes in the population of Serbia.
    PLoS One. 2024;19:e0312489.
    PubMed     Abstract available


  263. GIRAUD E, Fiette L, Melanitou E
    Type 1 diabetes and parasite infection: An exploratory study in NOD mice.
    PLoS One. 2024;19:e0308868.
    PubMed     Abstract available


  264. TISELL A, Soderberg K, Link Y, Lundberg P, et al
    Diffuse white matter pathology in multiple sclerosis during treatment with dimethyl fumarate-An observational study of changes in normal-appearing white matter using proton magnetic resonance spectroscopy.
    PLoS One. 2024;19:e0309547.
    PubMed     Abstract available


  265. FABER W, Stillebroer AB
    Addressing bladder and bowel challenges in dutch multiple sclerosis patients: Symptom prevalence and patient referral pathways.
    PLoS One. 2024;19:e0310691.
    PubMed     Abstract available


  266. NAFARI A, Vaheb S, Afshari-Safavi A, Ravankhah Z, et al
    Cancer and mortality risks among people with multiple sclerosis: A population-based study in Isfahan, Iran.
    PLoS One. 2024;19:e0312707.
    PubMed     Abstract available


  267. LI Y, Kong D, Ding Y, Wang J, et al
    The potential impact of COVID-19 vaccination on patients with immune thrombocytopenic purpura: A protocol for systematic review and meta-analysis.
    PLoS One. 2024;19:e0308546.
    PubMed     Abstract available


  268. IAQUINTO S, Ineichen BV, Salmen A, Kuhle J, et al
    Factors associated with low health-related quality of life in persons with multiple sclerosis: A quantile-based segmentation approach.
    PLoS One. 2024;19:e0312486.
    PubMed     Abstract available


  269. DE LA CRUZ A, Garces M, Larios E, Madera-Salcedo IK, et al
    Immune complex deposition promotes NK cell accumulation in the kidney.
    PLoS One. 2024;19:e0312141.
    PubMed     Abstract available


  270. MARIC GD, Pekmezovic TD, Tamas OS, Veselinovic ND, et al
    Investigation of differences between chronological and vascular age in persons with multiple sclerosis.
    PLoS One. 2024;19:e0311117.
    PubMed     Abstract available


  271. RIVERA-FRANCO N, Lopez-Alvarez D, Castillo A, Aristizabal E, et al
    Genomic variability in Zika virus in GBS cases in Colombia.
    PLoS One. 2024;19:e0313545.
    PubMed     Abstract available


  272. NAJMI EA, Mirzaasgari Z, Motamed MR, Aslani A, et al
    Carotid intima-media thickness and risk of atherosclerosis in multiple sclerosis: A cross-sectional study.
    PLoS One. 2024;19:e0314031.
    PubMed     Abstract available


  273. SALEEM O, Iqbal J
    Blood-glucose regulator design for diabetics based on LQIR-driven Sliding-Mode-Controller with self-adaptive reaching law.
    PLoS One. 2024;19:e0314479.
    PubMed     Abstract available


  274. ZURRER WE, Cannon AE, Ewing E, Bruschweiler D, et al
    STEED: A data mining tool for automated extraction of experimental parameters and risk of bias items from in vivo publications.
    PLoS One. 2024;19:e0311358.
    PubMed     Abstract available


  275. MIRMOSAYYEB O, Yazdan Panah M, Mokary Y, Mohammadi M, et al
    Neuroimaging markers and disability scales in multiple sclerosis: A systematic review and meta-analysis.
    PLoS One. 2024;19:e0312421.
    PubMed     Abstract available


  276. CHEIBCHALARD T, Leelahavanichkul A, Chatthanathon P, Klankeo P, et al
    Fungal microbiome in gut of systemic lupus erythematosus (SLE)-prone mice (pristane and FCGRIIb deficiency), a possible impact of fungi in lupus.
    PLoS One. 2024;19:e0314662.
    PubMed     Abstract available


  277. TSUNODA R, Kume K, Kagawa R, Sanuki M, et al
    Machine-learning-based identification of patients with IgA nephropathy using a computerized medical billing database.
    PLoS One. 2024;19:e0312915.
    PubMed     Abstract available


  278. RASOULI S, Dakkali MS, Ghazvini A, Azarbad R, et al
    Predictive model for converting optic neuritis to multiple sclerosis; decision tree in focus.
    PLoS One. 2024;19:e0309702.
    PubMed     Abstract available


  279. DESCHAMPS N, Nacher M, Preux PM, Takam V, et al
    Pattern, causes and functional outcome of peripheral neuropathies in the Amazon region.
    PLoS One. 2024;19:e0315760.
    PubMed     Abstract available


  280. SHRIWASH N, Aiman A, Singh P, Basir SF, et al
    Understanding the role of potential biomarkers in attenuating multiple sclerosis progression via multiomics and network-based approach.
    PLoS One. 2024;19:e0314428.
    PubMed     Abstract available


  281. LEE JY, Lee SB, Yang SW, Paik JS, et al
    Linsitinib inhibits IGF-1-induced cell proliferation and hyaluronic acid secretion by suppressing PI3K/Akt and ERK pathway in orbital fibroblasts from patients with thyroid-associated ophthalmopathy.
    PLoS One. 2024;19:e0311093.
    PubMed     Abstract available


  282. KOOSHKI A, Farmani R, Amirabadizadeh A, Mehrpour O, et al
    Essential and toxic metal concentrations in biological samples of multiple sclerosis patients: A systematic review and meta-analysis.
    PLoS One. 2024;19:e0313851.
    PubMed     Abstract available


  283. BIGDELI A, Ghaderi-Zefrehei M, Lesch BJ, Behmanesh M, et al
    Bioinformatics analysis of myelin-microbe interactions suggests multiple types of molecular mimicry in the pathogenesis of multiple sclerosis.
    PLoS One. 2024;19:e0308817.
    PubMed     Abstract available


    January 2023
  284. TEKIN H, Frobert O, Graesli AR, Kindberg J, et al
    Hibernation and plasma lipids in free-ranging brown bears-implications for diabetes.
    PLoS One. 2023;18:e0291063.
    PubMed     Abstract available


  285. LIN DY, Andreotti AH
    Structure of BTK kinase domain with the second-generation inhibitors acalabrutinib and tirabrutinib.
    PLoS One. 2023;18:e0290872.
    PubMed     Abstract available


  286. MONSTED MO, Holm LJ, Buschard K, Haupt-Jorgensen M, et al
    Failure to replicate the diabetes alleviating effect of a maternal gluten-free diet in non-obese diabetic mice.
    PLoS One. 2023;18:e0289258.
    PubMed     Abstract available


  287. HOWLAND S, Huber J, Aicken C
    Designing a brief and simple intervention to help young people with type 1 diabetes to live well: Protocol for developing a novel intervention with participation from young people.
    PLoS One. 2023;18:e0285300.
    PubMed     Abstract available


  288. SIKORSKI P, Li Y, Cheema M, Wolfe GI, et al
    Serum metabolomics of treatment response in myasthenia gravis.
    PLoS One. 2023;18:e0287654.
    PubMed     Abstract available


  289. POLICK CS, Ploutz-Snyder R, Braley TJ, Connell CM, et al
    Fatigue, pain interference, and psychiatric morbidity in multiple sclerosis: The role of childhood stress.
    PLoS One. 2023;18:e0292233.
    PubMed     Abstract available


  290. PHAM HN, Pham L, Sato K
    Bioinformatic analysis identified novel candidate genes with the potentials for diagnostic blood testing of primary biliary cholangitis.
    PLoS One. 2023;18:e0292998.
    PubMed     Abstract available


  291. PARK SS, Mai M, Ploszaj M, Cai H, et al
    Type 1 diabetes contributes to combined pulmonary fibrosis and emphysema in male alpha 1 antitrypsin deficient mice.
    PLoS One. 2023;18:e0291948.
    PubMed     Abstract available


  292. O'MALLEY N, Coote S, Staunton FM, O'Connor E, et al
    A core outcome set for evaluating the effectiveness of mixed-diagnosis falls prevention interventions for people with Multiple Sclerosis, Parkinson's Disease and stroke.
    PLoS One. 2023;18:e0294193.
    PubMed     Abstract available


  293. KRAKENES T, Wergeland S, Al-Sharabi N, Mohamed-Ahmed S, et al
    The neuroprotective potential of mesenchymal stem cells from bone marrow and human exfoliated deciduous teeth in a murine model of demyelination.
    PLoS One. 2023;18:e0293908.
    PubMed     Abstract available


  294. ABIDOV M, Sokolova K, Danilova I, Baykenova M, et al
    Hepatic insulin synthesis increases in rat models of diabetes mellitus type 1 and 2 differently.
    PLoS One. 2023;18:e0294432.
    PubMed     Abstract available


  295. CHENG CW, Fang WF, Lin JD
    Associations of serum keratin 1 with thyroid function and immunity in Graves' disease.
    PLoS One. 2023;18:e0289345.
    PubMed     Abstract available


  296. SUZUKI K, Iwata D, Namba K, Hase K, et al
    Involvement of Angiopoietin 2 and vascular endothelial growth factor in uveitis.
    PLoS One. 2023;18:e0294745.
    PubMed     Abstract available


  297. WALLE M, Arkew M, Asmerom H, Tesfaye A, et al
    The diagnostic accuracy of mean platelet volume in differentiating immune thrombocytopenic purpura from hypo-productive thrombocytopenia: A systematic review and meta-analysis.
    PLoS One. 2023;18:e0295011.
    PubMed     Abstract available


  298. ZHOU Q, Xiong Z, Yang D, Xiong C, et al
    The association between bullous pemphigoid and cognitive outcomes in middle-aged and older adults: A systematic review and meta-analysis.
    PLoS One. 2023;18:e0295135.
    PubMed     Abstract available


  299. HARVENGT AA, Polle OG, Martin M, van Maanen A, et al
    Post-Hypoglycemic hyperglycemia are highly relevant markers for stratification of glycemic variability and partial remission status of pediatric patients with new-onset type 1 diabetes.
    PLoS One. 2023;18:e0294982.
    PubMed     Abstract available


  300. TRENTIN-SONODA M, Cheff V, Gutsol A, Hebert RL, et al
    Sex-dependent effects of Canagliflozin on kidney protection in mice with combined hypertension-type 1 diabetes.
    PLoS One. 2023;18:e0295284.
    PubMed     Abstract available


  301. LORD SM, Bahnson HT, Greenbaum CJ, Liljenquist DR, et al
    Testing a new platform to screen disease-modifying therapy in type 1 diabetes.
    PLoS One. 2023;18:e0293268.
    PubMed     Abstract available


  302. FALLAH M, Najafi A, Balighi K, Daneshpazhooh M, et al
    Association of alternative healthy eating index and severity of pemphigus vulgaris: A cross-sectional study.
    PLoS One. 2023;18:e0295026.
    PubMed     Abstract available


  303. ABDULLAHI AS, Suliman A, Khan MA, Khair H, et al
    Temporal trends of hemoglobin among pregnant women: The Mutaba'ah study.
    PLoS One. 2023;18:e0295549.
    PubMed     Abstract available


  304. WILF-YARKONI A, Feldmann K, Rubarth K, Dorsch EM, et al
    Effectiveness of oral prednisone tapering following intravenous methylprednisolone for acute optic neuritis in multiple sclerosis.
    PLoS One. 2023;18:e0288366.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Autoimmune Disorders is free of charge.

Privacy / Datenschutzerklärung | Imprint / Impressum